LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 50 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,639,522 | +29.5% | 1,427,727 | +2.6% | 0.00% | – |
| Q2 2023 | $4,355,711 | -25.5% | 1,391,601 | +7.8% | 0.00% | – |
| Q1 2023 | $5,850,087 | +30.4% | 1,291,410 | +18.9% | 0.00% | – |
| Q4 2022 | $4,486,890 | +46.9% | 1,086,414 | +13.8% | 0.00% | – |
| Q3 2022 | $3,055,000 | +204.9% | 954,760 | +86.8% | 0.00% | – |
| Q2 2022 | $1,002,000 | -51.6% | 511,082 | 0.0% | 0.00% | – |
| Q1 2022 | $2,070,000 | -63.5% | 511,082 | -2.8% | 0.00% | – |
| Q4 2021 | $5,676,000 | +20.0% | 526,043 | +28.2% | 0.00% | – |
| Q3 2021 | $4,731,000 | -27.5% | 410,316 | -38.2% | 0.00% | – |
| Q2 2021 | $6,525,000 | -6.1% | 664,370 | +39.7% | 0.00% | – |
| Q1 2021 | $6,947,000 | -29.9% | 475,536 | +2.8% | 0.00% | – |
| Q4 2020 | $9,905,000 | +193.2% | 462,676 | +107.8% | 0.00% | – |
| Q3 2020 | $3,378,000 | +217.8% | 222,661 | +169.2% | 0.00% | – |
| Q2 2020 | $1,063,000 | – | 82,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |